Literature DB >> 18704098

Mechanisms of withdrawal-associated increases in heroin self-administration: pharmacologic modulation of heroin vs food choice in heroin-dependent rhesus monkeys.

S Stevens Negus1, Kenner C Rice.   

Abstract

Opioid withdrawal can produce a constellation of physiological and behavioral signs, including an increase in opioid self-administration. Different mechanisms mediate different withdrawal signs, and the present study used pharmacologic tools to assess mechanisms underlying withdrawal-associated increases in opioid reinforcement. Five rhesus monkeys were rendered heroin dependent via daily 21-h heroin self-administration sessions. One hour after each heroin self-administration session, monkeys chose between heroin (0-0.1 mg/kg per injection) and food (1 g pellets) during 2-h choice sessions. Under these conditions, heroin maintained a dose-dependent increase in heroin choice, such that monkeys responded primarily for food when low heroin doses were available (0-0.01 mg/kg per injection) and primarily for heroin when higher heroin doses were available (0.032-0.1 mg/kg per injection). Periods of spontaneous withdrawal were intermittently introduced by omitting one 21-h heroin self-administration session, and test drugs were administered during these withdrawal periods. Untreated withdrawal robustly increased heroin choice during choice sessions. Withdrawal-associated increases in heroin choice were completely suppressed by the mu opioid agonist morphine (0.032-0.32 mg/kg/h, i.v.), but not by the alpha-2 noradrenergic agonist clonidine (0.01-0.1 mg/kg/h, i.v.), the dopamine/norepinephrine releaser amphetamine (0.032-0.1 mg/kg/h, i.v.), or the kappa-opioid antagonist 5'-guanidinonaltrindole (1.0 mg/kg, i.m.). The corticotropin-releasing factor 1 antagonist antalarmin (1.0-10 mg/kg per day, i.m.) produced a morphine-like suppression of withdrawal-associated increases in heroin choice in one of three monkeys. These results suggest that mechanisms of withdrawal-associated increases in the relative reinforcing efficacy of opioid agonists may be different from mechanisms of many other somatic, mood-related, and motivational signs of opioid withdrawal.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18704098      PMCID: PMC2639629          DOI: 10.1038/npp.2008.127

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  58 in total

1.  Noradrenergic hyperactivity in opiate withdrawal supported by clonidine reversal of opiate withdrawal.

Authors:  M S Gold; D E Redmond; H D Kleber
Journal:  Am J Psychiatry       Date:  1979-01       Impact factor: 18.112

Review 2.  Precipitated morphine withdrawal in rats as a tool in opiate research.

Authors:  J Bläsig; A Herz
Journal:  Curr Dev Psychopharmacol       Date:  1977

3.  Discrete-trial choice procedure: effects of naloxone and methadone on choice between food and heroin.

Authors:  R R Griffiths; R M Wurster; J V Brady
Journal:  Pharmacol Rev       Date:  1975-09       Impact factor: 25.468

4.  Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal.

Authors:  S.C. Heinrichs; F. Menzaghi; G. Schulteis; G.F. Koob; L. Stinus
Journal:  Behav Pharmacol       Date:  1995-01       Impact factor: 2.293

5.  Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion.

Authors:  J M Delfs; Y Zhu; J P Druhan; G Aston-Jones
Journal:  Nature       Date:  2000-01-27       Impact factor: 49.962

6.  Cocaine and amphetamine attenuate the discriminative stimulus effects of naltrexone in opioid-dependent rhesus monkeys.

Authors:  Stacy L Sell; Charles P France
Journal:  J Pharmacol Exp Ther       Date:  2002-06       Impact factor: 4.030

7.  Choice between food and heroin: effects of morphine, naloxone, and secobarbital.

Authors:  R R Griffiths; R M Wurster; J V Brady
Journal:  J Exp Anal Behav       Date:  1981-05       Impact factor: 2.468

8.  Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.

Authors:  Luis Stinus; Martine Cador; Eric P Zorrilla; George F Koob
Journal:  Neuropsychopharmacology       Date:  2005-01       Impact factor: 7.853

9.  Clonidine blocks acquisition but not expression of conditioned opiate withdrawal in rats.

Authors:  G Schulteis; L Stinus; V B Risbrough; G F Koob
Journal:  Neuropsychopharmacology       Date:  1998-11       Impact factor: 7.853

10.  Low dose naltrexone administration in morphine dependent rats attenuates withdrawal-induced norepinephrine efflux in forebrain.

Authors:  Elisabeth J Van Bockstaele; Yaping Qian; Robert C Sterling; Michelle E Page
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2008-03-25       Impact factor: 5.067

View more
  35 in total

Review 1.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

Review 2.  Agonist replacement therapy for cocaine dependence: a translational review.

Authors:  Craig R Rush; William W Stoops
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

3.  Abuse-related effects of µ-opioid analgesics in an assay of intracranial self-stimulation in rats: modulation by chronic morphine exposure.

Authors:  Ahmad A Altarifi; Kenner C Rice; S Stevens Negus
Journal:  Behav Pharmacol       Date:  2013-09       Impact factor: 2.293

4.  Intermittent Access to Ethanol Induces Escalated Alcohol Consumption in Primates.

Authors:  S G Lindell; M L Schwandt; S J Suomi; K C Rice; M Heilig; C S Barr
Journal:  J Addict Behav Ther Rehabil       Date:  2017-04-07

5.  Lorcaserin maintenance fails to attenuate heroin vs. food choice in rhesus monkeys.

Authors:  E Andrew Townsend; S Stevens Negus; Justin L Poklis; Matthew L Banks
Journal:  Drug Alcohol Depend       Date:  2020-01-17       Impact factor: 4.492

Review 6.  The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse.

Authors:  Sunmee Wee; George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2010-03-30       Impact factor: 4.530

Review 7.  Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.

Authors:  George F Koob
Journal:  Pharmacol Rev       Date:  2021-01       Impact factor: 25.468

Review 8.  Modulation of drug choice by extended drug access and withdrawal in rhesus monkeys: Implications for negative reinforcement as a driver of addiction and target for medications development.

Authors:  S Stevens Negus; Matthew L Banks
Journal:  Pharmacol Biochem Behav       Date:  2017-04-22       Impact factor: 3.533

9.  Effects of extended cocaine access and cocaine withdrawal on choice between cocaine and food in rhesus monkeys.

Authors:  Matthew L Banks; S Stevens Negus
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

Review 10.  Principles of laboratory assessment of drug abuse liability and implications for clinical development.

Authors:  Lawrence P Carter; Roland R Griffiths
Journal:  Drug Alcohol Depend       Date:  2009-05-14       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.